Class II · Moderate risk
Rivastigmine Transdermal System
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Is Rivastigmine recalled?
Not under an active recall.
Rivastigmine was recalled 3 times in the past — all now closed. Most recent: Jan 26, 2022.
Most common reason: Cross-contamination (1 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Rivastigmine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Rivastigmine recalls on record
none so far in 2026; 3 on record, newest first
Class III · Low risk
RIVASTIGMINE Tartrate Capsules
Cross-contamination with other products -Related Substances test for Rivastigmine Tartrate Capsules USP, 1.5 mg showed a peak for Ranitidine.
Class II · Moderate risk
Rivastigmine Tartrate Capsules
Failed Dissolution Specifications
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.